Magnesium Glycinate vs Citrate: Sleep, Anxiety, Absorption (2026)
For sleep and anxiety, magnesium glycinate (bisglycinate) has stronger dedicated RCT evidence than magnesium citrate — specifically the 2025 Schuster bisglycinate trial (n=155, Cohen's d = 0.2 on Insomnia Severity Index). Magnesium citrate is better absorbed than oxide and suitable for general magnesium repletion, but no sleep-specific RCT has used citrate as the primary intervention form. The right choice depends on your primary goal and your GI tolerance at higher doses.
TL;DR
- Magnesium glycinate has one dedicated 2025 sleep RCT (n=155, Cohen's d = 0.2); citrate does not have a sleep-specific trial [1]
- Citrate outperforms oxide in bioavailability in a head-to-head human crossover trial (Walker et al. 2003) [2]
- Glycinate pairs magnesium with glycine, an inhibitory amino acid that potentiates GABA-A receptors — the sleep-pathway logic is well-defined [3]
- Citrate causes laxative effect at doses ≥300 mg elemental — relevant if you need the full 400 mg sleep dose [4]
- No head-to-head glycinate vs. citrate sleep RCT exists as of 2026 — this comparison draws on bioavailability trials and form-specific RCTs
Side-by-side at a glance
Magnesium Glycinate vs Citrate — key properties compared
| Property | Magnesium Glycinate | Magnesium Citrate |
|---|---|---|
| Bioavailability | High — amino acid transport pathway | High — organic salt, superior to oxide |
| Dedicated sleep RCT | Yes — Schuster 2025, n=155, d=0.2 | No dedicated sleep trial |
| Typical elemental dose | 100–200 mg | 150–200 mg |
| GI tolerance | Minimal side effects | Laxative at ≥300 mg elemental |
| GABA-A pathway | Yes — glycine co-factor | Indirect — no glycine |
| Cost (30-day supply) | $15–$30 USD | $8–$20 USD |
| Forms available | Capsule, powder | Capsule, powder, liquid |
| Evidence for anxiety | Indirect (Boyle 2017 meta-analysis) | Indirect (magnesium repletion only) |
What is magnesium glycinate?
Magnesium glycinate (also called magnesium bisglycinate) is magnesium chelated with glycine, a non-essential amino acid. The chelate structure increases intestinal absorption: glycine is absorbed via dedicated amino acid transporters (PEPT1 and SLC family), pulling the magnesium along with it rather than competing for the non-specific passive transport that oxide relies on.
Glycine itself is an inhibitory neurotransmitter that modulates glycine receptors in the brainstem and spinal cord, and acts as a co-agonist at NMDA receptors. Separately, magnesium potentiates GABA-A receptor activity by maintaining the receptor's responsiveness to GABA. The combined effect — two converging sedative-pathway mechanisms — makes glycinate theoretically the most sleep-targeted form available without prescription.
Schuster et al. (2025) tested 250 mg elemental magnesium as bisglycinate versus placebo in 155 adults with self-reported poor sleep quality over 8 weeks. ISI (Insomnia Severity Index) scores fell significantly more in the magnesium group from Week 4 onwards, with Cohen's d = 0.2 at week 8.
"The magnesium bisglycinate group showed a significantly greater reduction in ISI scores compared to the placebo group from baseline to Week 4, with an effect size of Cohen's d = 0.2."
Cohen's d = 0.2 is a small effect by convention. In the context of a non-prescription supplement compared to placebo in a non-clinically-insomniac population, it is a real and detectable signal. The 2021 Mah and Pitre meta-analysis (3 RCTs, 151 older adults) found sleep onset latency fell 17 minutes post-magnesium vs. placebo — magnitude consistent with the Schuster findings.
Boyle et al. (2017), a meta-analysis of 18 human studies in Nutrients, found magnesium supplementation reduced subjective anxiety across populations, consistent with the GABA-A mechanism that glycinate leverages.
"The current data are suggestive of a beneficial effect of Mg on subjective anxiety in vulnerable groups. More research is needed to confirm this finding."
What is magnesium citrate?
Magnesium citrate is magnesium bound to citric acid. It is an organic salt with meaningfully better bioavailability than magnesium oxide — the form most commonly used in the oldest and most-cited sleep trial (Abbasi et al. 2012). Walker et al. (2003) demonstrated citrate's bioavailability advantage over oxide in a randomized human crossover trial using urinary magnesium as proxy for absorption.
"Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study."
Citrate is widely available, affordable, and a reasonable first-choice form for correcting dietary magnesium deficiency. The NIH ODS estimates approximately 48% of US adults consume less magnesium than their Estimated Average Requirement — citrate is a cost-effective repletion route.
The practical limitation for sleep dosing: osmotic laxative effect above approximately 300 mg elemental magnesium. Since most sleep trials cluster in the 200–400 mg range, citrate at the higher end of the therapeutic dose can produce GI disturbance before it produces sleep benefit. Glycinate largely avoids this because the amino acid chelate transports the mineral before the osmotic action kicks in.
No study has specifically randomized participants to magnesium citrate versus placebo with sleep as the primary endpoint. Citrate appears in some multi-form trials but not as the sole intervention.
Which works better for sleep?
The evidence gap between glycinate and citrate for sleep is not evidence that citrate doesn't work — it is evidence that nobody has run the citrate-specific sleep trial. Magnesium's sleep benefit is thought to operate through systemic magnesium repletion (correcting the ~17-minute sleep-onset benefit documented in deficient populations) combined with the glycine GABA-A pathway. Citrate delivers the magnesium; glycinate delivers both the magnesium and the glycine.
If your dietary magnesium is already near-adequate and your primary target is sleep quality, glycinate is the rational form choice. If your primary target is correcting magnesium deficiency and cost matters, citrate is a reasonable starting point with comparable absorption.
Which works better for anxiety?
Neither glycinate nor citrate has a dedicated anxiety RCT. The Boyle et al. (2017) meta-analysis covers 18 studies across forms and populations — the anxiety signal is real but weak, and the review notes that effect is most consistent in "vulnerable groups" (anxiety-prone or deficient populations). The glycine component of glycinate carries some independent anxiolytic credibility: oral glycine at 3g reduced subjective anxiety and sleep latency in Bannai et al. (2012, Sleep and Biological Rhythms), though that trial used standalone glycine supplements, not the glycinate chelate.
"Glycine ingestion significantly improved the quality of sleep in subjects who had a restriction of sleep time... and improved daytime sleepiness and fatigue."
For anxiety specifically, neither form has convincing superiority. Magnesium repletion itself may reduce HPA axis reactivity regardless of form — if deficiency is the driver, any well-absorbed form will help.
Side effects and contraindications
Both forms are well-tolerated at typical doses. Key differences:
Magnesium glycinate: Minimal GI effects at doses up to 400 mg elemental. Rare: headache reported at high doses. Contraindication: severe renal impairment (hypermagnesemia risk applies to all forms). Drug interaction: proton pump inhibitors (omeprazole, pantoprazole, esomeprazole) impair TRPM6/TRPM7 absorption for all oral magnesium forms.
Magnesium citrate: Laxative effect begins at approximately 300 mg elemental. This is intentional and pharmacologically used at higher doses (1–2g) for bowel preparation. At therapeutic sleep doses (150–250 mg elemental), GI effects are usually minor. Same renal and PPI interactions as glycinate.
"Active transport via TRPM6/7 channels is disrupted in PPI-induced hypomagnesemia... urinary magnesium was low in all studies."
Cost and form factor
Magnesium glycinate: $15–$30 USD for a 30-day supply at 200–400 mg elemental, depending on brand. Available as capsules and powder. The chelate adds manufacturing cost over oxide or citrate.
Magnesium citrate: $8–$20 USD for a 30-day supply. Available as capsules, powder, and flavored liquid (the liquid form is commonly used for bowel prep — confirm the dose per serving is in the sleep-relevant range, not the laxative range, when purchasing).
Generic versions of both forms meet the same elemental magnesium content as branded products. "Albion chelate" branding on glycinate products refers to a specific chelation process; no independent RCT has compared Albion-chelated bisglycinate against other glycinate preparations.
Verdict
Magnesium glycinate is the better-evidenced choice for sleep, with one dedicated 2025 RCT producing a real (if modest) signal at Cohen's d = 0.2. The glycine co-factor adds a plausible independent anxiolytic mechanism beyond magnesium repletion. GI tolerance is better at doses up to 400 mg elemental.
Magnesium citrate is a well-absorbed, affordable form that is appropriate for general magnesium repletion. If sleep is not the primary goal — or if cost is a limiting factor — citrate covers the deficiency gap that drives most of the population-level sleep benefit anyway. It is a worse choice at doses above 300 mg elemental where the osmotic effect begins.
The critical caveat for both forms: the benefit concentrates in people running below the magnesium EAR — approximately 48% of US adults. If your dietary magnesium is already adequate, neither form is likely to move your sleep metrics. The 17-minute sleep-onset improvement and the Cohen's d = 0.2 signal are population effects in deficient groups.
No head-to-head glycinate vs. citrate trial exists. This comparison is drawn from form-specific trials and bioavailability data — not from a direct randomized comparison.
Related transmissions
Magnesium for Sleep: What 60+ Studies Show — full deep-dive on all magnesium forms, doses, timing, and the landmark 2025 bisglycinate RCT.
Anxiety Natural Remedies: The Evidence — magnesium in the context of the full non-prescription anxiety intervention landscape.
FAQ
Is magnesium glycinate better than citrate for sleep?
By available RCT evidence, yes — glycinate has one dedicated 2025 sleep trial (n=155, Cohen's d = 0.2 at 250 mg elemental) and citrate does not. The glycine co-factor also provides a GABA-A potentiation mechanism independent of magnesium repletion. That said, no head-to-head trial compares them directly for sleep.
Can I take both magnesium glycinate and citrate together?
Combining forms is generally safe but rarely necessary. Total elemental magnesium intake should stay below approximately 350 mg/day from supplementation (NIH ODS upper limit for supplemental magnesium; the tolerable upper intake level including dietary sources is 350 mg for adults). Splitting forms adds complexity without documented benefit.
Which magnesium is best absorbed?
Both glycinate and citrate are among the better-absorbed forms compared to oxide (which has approximately 4% absorption in some estimates). Human crossover data (Walker 2003) shows citrate outperforms oxide. Glycinate uses a dedicated amino acid transport pathway. Neither has been shown to significantly outperform the other in direct head-to-head absorption trials.
Does magnesium citrate help with anxiety?
Magnesium repletion broadly reduces subjective anxiety in deficient populations (Boyle et al. 2017, 18 studies). Citrate is a well-absorbed form for achieving that repletion. However, the anxiety signal is modest and concentrated in populations with low magnesium status. Citrate has no dedicated anxiety RCT.
Sources
- Schuster J, et al. (2025). Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial. Nature and Science of Sleep. PMC12412596.
- Walker AF, Marakis G, Christie S, Byng M. (2003). Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnesium Research. PubMed 14596323.
- Boyle NB, Lawton C, Dye L. (2017). The Effects of Magnesium Supplementation on Subjective Anxiety and Stress — A Systematic Review. Nutrients, 9(5). PMC5452159.
- Mah J, Pitre T. (2021). Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis. BMC Complementary Medicine and Therapies, 21, 125. PMC8053283.
- Gommers LM, Hoenderop JG, de Baaij JH. (2022). Mechanisms of proton pump inhibitor-induced hypomagnesemia. Acta Physiologica. PMC9539870.
- Bannai M, Kawai N, Ono K, Nakahara K, Murakami N. (2012). New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. Sleep and Biological Rhythms. PubMed 25237036.
- NIH Office of Dietary Supplements. (2022). Magnesium — Health Professional Fact Sheet. ods.od.nih.gov.
- Abbasi B, Kimiagar M, Sadeghniiat K, Shirazi MM, Hedayati M, Rashidkhani B. (2012). The effect of magnesium supplementation on primary insomnia in elderly. Journal of Research in Medical Sciences. PMC3703169.
- Held K, Antonijevic IA, Künzel H, et al. (2002). Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry, 35(4). PubMed 12163983.
- Zhang Y, Chen C, Lu L, et al. (2022). Association of magnesium intake with sleep duration and sleep quality: findings from the CARDIA study. Sleep (Oxford Academic). PMC8996025.